Loading...

PULM PULMATRIX INC US FDA Inspections 8-K Filing

PLMT

PLM

PULMATRIX INC

(PULM)

2023 8-K

Summary

Summary

Financial Results Report

Financial Statements

Merger of Equals

Financial Statements

Financial Results

Bylaw Amendment

Annual Meeting Results

Merger Agreement

Financial Results

Annual Meeting Notice

Q2 Financial Results

Departure of Directors and ...

Agreement for Facility Tran...

Earnings Reports

Earnings Reports

Termination of Chief Medica...

Presentation Distribution

Termination of Clinical Stu...

Earnings Reports

Earnings Reports

Earnings Reports

Earnings Reports

Announcement of Phase 2b Tr...

Regulation FD Disclosure

Investor Presentation

Phase 1 Trial Completion

External Links:

Pulmatrix, Inc. announced the first patient dosed in a Phase 2b trial for PUR1900 in subjects with Allergic Bronchopulmonary Aspergillosis (ABPA) and asthma.

AI Assistant

PULMATRIX INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.